Vous êtes ici

Isodiol International Inc.

Liste d'échange: 
CSE
Statut: 
Delisted
Industrie: 
Diversified Industries
Symbole: 
ISOL
Indice CSE: 
Devise: 

Isodiol International Inc. ("Isodiol"), focused on the nutritional health benefits  derived from hemp, is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.

Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Isodiol has received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products. 

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and aggressively continue international expansion into Latin America, Asia, and Europe.

Vous êtes ici

Isodiol International Inc. (ISOL)

SEDAR Information

Information d'entreprise

Addresse
Suite 2200, 885 West Georgia Street
Vancouver, BC V6C 3E8
Canada
Téléphone
604-409-4409
Courriel
ir@isodiol.com
URL
https://isodiol.com/
Date d’inscription à la cote
Mardi, juillet 8, 2014
Agent de transfert
Computershare Investor Services Inc.
Courriel
ir@isodiol.com
Vérificateur
Davidson & Company LLP, Chartered Professional Accountants

Capitalisation

Capitalisation: 
128534359
Réservé à l'émission: 
2607754

Company Officers

Marcos Agramont, Chief Executive Officer, Chief Operating Officer
Andrew Alvis, President and Interim Chief Financial Officer

Bulletins

06/12/2021

2021-1206 - Radiation - Isodiol International Inc. (ISOL)

Le 6 décembre/December 2021

The common shares of Isodiol International Inc. will be delisted at the market close today December 6, 2021.

Isodiol International is currently suspended. See bulletin 2020-1214.

___________________

Les actions ordinaires de Isodiol International Inc. seront radiées de la cote à la clôture du marché aujourd'hui, le 6 décembre 2021.